Search

Search Constraints

You searched for: Author/Creator Petta, S.

Search Results

3. A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Issue 5 (2nd July 2018)

4. AA genotype of deSNP rs6726639 of MERTK gene is associated with development of Hepatocellular Carcinoma after eradication of Hepatitis C Virus infection. (February 2019)

5. AF.81 NONINVASIVE ASSESSMENTS TO IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: SCREENED POPULATION FROM THE REGENERATE TRIAL. (September 2021)

6. AF.87 RESIST-HCV CRITERIA ARE ABLE TO RULE OUT ESOPHAGEAL VARICES PROGRESSION IN PATIENTS WITH HCV CIRRHOSIS TREATED BY DIRECT-ACTING ANTIVIRAL AGENTS(DAAS). (September 2021)

7. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. Issue 7 (25th March 2013)

8. ATG7 genetic variant and defective autophagy: a novel risk factor for non-alcoholic fatty liver disease progression in patients with type 2 diabetes mellitus. (February 2019)

9. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. (27th December 2017)

10. Changes in 13C-aminopyrine breath test predict liver-related events and death in patients with HCV-related previous decompensated child A5 or child A6 to B cirrhosis who achieve SVR after DAA therapy. (February 2019)